CA-LIVERAMP
LiveRamp (NYSE: RAMP) today announced new clean room activation and cloud-first identity capabilities that empower clients to more effectively activate and connect their data while unlocking deeper analytics and audience insights. As a result, brands, publishers, and technology platforms can maximize the value of their first-party data, seamlessly unify and activate their data from any environment, and deepen consumer insights through more granular measurement—all within their existing enterprise technology stack or partner ecosystem.
With these platform enhancements, LiveRamp’s 900+ clients now benefit from:
Activation to Hundreds of Partners Directly from Snowflake’s and LiveRamp’s Data Clean Room. With LiveRamp’s next-generation, cloud-native clean room capabilities, clients can now activate their data with hundreds of partners directly from their collaboration platform of choice, including Snowflake and the LiveRamp Clean Room, with enhanced accuracy and connectivity.
With RampID™—the most durable, privacy-centric identifier for connecting the digital ecosystem—LiveRamp clients can take immediate action on new insights generated through secure partner collaborations while achieving incomparable scale and reach. With seamless connectivity to the industry’s most expansive, data-rich network, LiveRamp also offers the ability to activate across this ecosystem without the need to use multiple solutions or build a new integration for each partner and platform.
“Partnering with LiveRamp to evolve clean room capabilities through our Converged platform and ecosystem has helped to improve first-party data activation and create targeted, accurate audience segments – all from the same environment," said Mike Bregman, Chief Activation Officer at Havas Media Network North America. "This has enabled Havas Media to better assist clients who increasingly need cross-channel insights to reach business goals.”
“Data clean rooms have become a critical tool for delivering more customer intelligence to our brand partners while maintaining the transparency and control we require as a steward of our audiences’ data,” said Brian Lin, Senior Vice President of Product Management, Advertising at TelevisaUnivision. “The ability to activate directly out of LiveRamp’s next-generation clean room deepens the expanse of our strategic partnerships while maintaining the highest level of privacy protections.”
Industry-First Identity Resolution Across All Major Clouds. With cloud-native and embedded identity resolution capabilities, clients can now choose to expand their pseudonymised first-party data to include known data elements, such as CRM and email addresses, directly in their preferred cloud platform, including AWS, Azure, Google Cloud, Databricks, and Snowflake. LiveRamp clients can now maximize marketing ROI from wherever their data lives.
Fragmentation of customer data makes unlocking person-based identity in the cloud an ongoing challenge. For example, 86% of consumers have multiple email addresses, which need to be resolved to an individual to enable best-in-class activation and measurement. Consumers also, on average, have 13 connected devices that may be leveraged for a holistic advertising and measurement strategy. Household-specific purchasing patterns are also changing, making it difficult to accurately measure attribution. Using LiveRamp’s cloud-first identity capabilities companies are able to address these challenges by resolving multiple personal identifiers back to an individual and a household, thus enhancing measurement and enabling more personalized advertising while minimizing the need for data movement.
“The ability to utilize LiveRamp’s technology without leaving our cloud environment is an incredible benefit,” said Seth Hirsh, Partner, Head of Analytics at Acadia. “As we look to our future on Snowflake, LiveRamp will give us the tools to streamline how we onboard data to cloud data warehouses, target audiences broadly across the ecosystem, and improve measurement outcomes for our clients without having to move data between environments.”
Kimberly Bloomston, SVP of Product at LiveRamp, added, “Bringing cloud-native, clean room-optimized activation and identity capabilities to the market ensures enterprises have the ability to scale data practices, maximize insights, and build flexibility for the future. The new features deliver access to otherwise inaccessible datasets, allowing them to simplify campaign activation and optimize the ability to reach consumers in a consistently accurate manner. With LiveRamp, businesses are empowered to evolve their digital transformation initiatives alongside the demands of a vastly fragmented ecosystem and complex journeys of their customers and partners, including clouds and clean rooms.”
LiveRamp continues to advance its solutions and power next-generation data collaboration across four critical components.
- Live/Identity: Build the enterprise identity infrastructure to accurately identify and match customers across channels, partners, and platforms for the most connected customer view possible.
- Live/Access: Expand the value of data, deepen customer understanding, and reach new audiences with LiveRamp’s network of high-quality data partners.
- Live/Connectivity: Overcome signal loss, embrace the future of addressability, and connect with high-value audiences at scale, wherever they’re spending time.
- Live/Insights: Fuel innovation and unlock powerful measurement and analytics with robust clean room capabilities, with advanced controls and permissioning and cutting-edge privacy-enhancing technologies built in.
Learn more about customizing LiveRamp’s solutions for your unique business needs on our website.
About LiveRamp
LiveRamp is the data collaboration platform of choice for the world’s most innovative companies. A groundbreaking leader in consumer privacy, data ethics, and enterprise identity, LiveRamp is setting the new standard for building a connected customer view with unmatched clarity and context while protecting precious brand and consumer trust. LiveRamp offers complete flexibility to collaborate wherever data lives to support the widest range of data collaboration use cases—within organizations, between brands, and across its premier global network of top-quality partners.
Hundreds of global innovators, from iconic consumer brands and tech giants to banks, retailers, and healthcare leaders turn to LiveRamp to build enduring brand and business value by deepening customer engagement and loyalty, activating new partnerships, and maximizing the value of their first-party data while staying on the forefront of rapidly evolving compliance and privacy requirements. LiveRamp is based in San Francisco, California with offices worldwide. Learn more at www.liveramp.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231010528287/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 07:00:00 CEST | Press release
- First patient enrolled in INFLAM MOTION, a global randomized Phase 2a trial including 129 knee osteoarthritis patients - 4P004 to be evaluated over 3 months for dual efficacy: symptom relief and synovial health improvement via contrast-enhanced MRI - Topline results expected in the second half of 2026 4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P
Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 19:06:00 CEST | Press release
With Qi2.2 certification, Belkin reinforces its commitment to quality, safety, and performance for the next generation of wireless charging Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The comp
Cessna Grand Caravan EX to Feature New Executive Interior Options, Expanding Opportunities for Elevated Missions15.7.2025 18:05:00 CEST | Press release
The legendary Cessna Grand Caravan EX will now feature three new executive interior schemes for customers to select when designing their aircraft cabin. The Lunar, Obsidian and Saddle Sport interiors join the existing Canyon and Savanna schemes, providing a broader range of standard choices. The new interior options are available to customers starting this month and allow them to further tailor the interior of their aircraft based on their personal preference or mission. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715021096/en/ Cessna Grand Caravan EX to feature new executive interior options, expanding opportunities for elevated missions (Photo Credit: Textron Aviation) The Cessna Grand Caravan EX is designed and manufactured by Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company. Premium versions of each of the new interiors are also available, featuring quilted seat stitching and plush carpet, providing an elev
7 Million Tokens Sells Out in less than One Hour—$MBG Token Pre-Sale Shatters Expectations15.7.2025 17:27:00 CEST | Press release
MultiBank Group, the world’s largest and most regulated financial derivatives institution, has set a new benchmark in digital asset launches. The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715055611/en/ The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. Commenting on the success of the Pre-Sale, Naser Taher, Founder and Chairman of MultiBank Group, said: “The sell-out of our initial $MBG Token offering in less than one hour is a decisive validation of our vision. In a market saturated with speculation, the response we received confirms that institutional-grade transparency, regulatory integrity, and asset-backed value are what investors are now demanding. $MBG is here for the long term, reflecting t
First Patient Enrolled in National Cancer Institute’s Vanguard Study Evaluating Guardant Health’s Shield Multi-Cancer Detection Test15.7.2025 17:01:00 CEST | Press release
Study addressing feasibility of using multi-cancer detection tests in future trials aims to enroll up to 24,000 participantsShield MCD reviewed by FDA as part of NCI’s investigational device exemption (IDE) Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that patient enrollment has begun in the National Cancer Institute (NCI)’s Vanguard Study to evaluate emerging multi-cancer detection (MCD) technology. Guardant’s Shield™ MCD test was selected for use in the four-year study, which aims to enroll up to 24,000 patients and evaluate the use of MCD tests—blood tests that can screen for several types of cancer simultaneously—in future randomized controlled trials. Guardant’s Shield MCD test was chosen for the study based on the overall performance of its Shield platform in detecting 10 cancer types, including lung, breast, colorectal, prostate, bladder, ovarian, pancreatic, esophageal, liver and gastric. The data were presented at the 2025 American
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom